Community pharmacy-delivered interventions for public health priorities: A systematic review of interventions for alcohol reduction, smoking cessation and weight management, including meta-analysis for smoking cessation

BMJ Open

Volumn 6, Issue 2, 2016, Pages

  Brown, Tamara J ^a,b   Todd, Adam ^a,b   O'malley, Claire ^a,b   Moore, Helen J ^a,b   Husband, Andrew K ^a,b   Bambra, Clare ^a,b   Kasim, Adetayo ^a   Sniehotta, Falko F ^b,c   Steed, Liz ^d   Smith, Sarah ^a,b   Nield, Lucie ^e   Summerbell, Carolyn D ^a,b  

^a DURHAM UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; AUSTRALIA; BEHAVIOR CHANGE; BEHAVIOR THERAPY; BODY MASS; BODY WEIGHT MANAGEMENT; CLINICAL EFFECTIVENESS; COMMERCIAL PHENOMENA; CONSULTATION; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; FOLLOW UP; HEALTH CARE DELIVERY; HUMAN; META ANALYSIS; NICOTINE REPLACEMENT THERAPY; PATIENT CARE; PATIENT EDUCATION; PHARMACIST; PHARMACY; PRIMARY MEDICAL CARE; PUBLIC HEALTH SERVICE; RANDOMIZED CONTROLLED TRIAL (TOPIC); ROLE PLAYING; SMOKING CESSATION; SOCIAL STATUS; STUDY DESIGN; SYSTEMATIC REVIEW; UNITED KINGDOM; UNITED STATES; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; AGE; COST BENEFIT ANALYSIS; DRINKING BEHAVIOR; ECONOMICS; ETHNOLOGY; ORGANIZATION AND MANAGEMENT; PREVENTION AND CONTROL; SEX DIFFERENCE; SOCIOECONOMICS;

AGE FACTORS; ALCOHOL DRINKING; BEHAVIOR THERAPY; COMMUNITY PHARMACY SERVICES; COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE; HUMANS; SEX FACTORS; SMOKING CESSATION; SOCIOECONOMIC FACTORS; UNITED STATES; WEIGHT LOSS;

EID: 84960452475     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-009828     Document Type: Article

References (46)

1. World Health Organization. Global strategy on diet, physical activity and health. Geneva: World Health Organization, 2004.
2. Bambra C, Joyce K, Maryon-Davies A. Strategic Review of Health Inequalities in England post-2010 London; (Marmot review) (Task Group 8: Priority Public Health Conditions: Final Report). London: University College London Institute of Health Equity, 2009.
3. Todd A, Copeland A, Husband A, et al. Access all areas? An area-level analysis of accessibility to general practice and community pharmacy services in England by urbanity and social deprivation. BMJ Open 2015;5:e007328.
4. Todd A, Copeland A, Husband A, et al. The positive pharmacy care law: an area-level analysis of the relationship between community pharmacy distribution, urbanity and social deprivation in England. BMJ Open 2014;4:e005764.
5. Pharmaceutical Services Negotiating Committee. Service specifications and resources. http://psnc.org.uk/service-searchresults/? location-of-service=293&type-of-service=387&method-ofcommissioning=& funding source=&wqsfsubmit=Filter (accessed 17 Jun. 2015).
6. Peterborough Pharmaceutical Needs Assessment. Peterborough City Council, 2015. https://www.peterborough.gov. uk/upload/www.peterborough.gov. uk/healthcare/public-health/Healthcare-PublicHealth-PeterboroughPNA2015.pdf?inline=true (accessed 30 Jun. 2015).
7. Department of Health. Pharmacy in England: building on strengths delivering the future. London: Department of Health, 2008.
8. Gordon J, Watson M, Avenell A. Lightening the load? A systematic review of community pharmacy-based weight management interventions. Obes Rev 2011;12:897-911.
9. Watson MC, Blenkinsopp A. The feasibility of providing community pharmacy based services for alcohol misuse: a literature review. Int J Pharm Pract 2009;17:199-205.
10. Sinclair HK, Bond CM, Stead LF. Community pharmacy personnel interventions for smoking cessation. Cochrane Database Syst Rev 2004;(1): CD003698.
11. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration, 2011.
12. Todd A, Moore HJ, Husband AK, et al. Community pharmacy interventions for public health priorities: protocol for a systematic review of community pharmacy delivered smoking, alcohol and weight management interventions. Syst Rev 2014;3:93.
13. Moher D, Liberati A, Tetzlaff J, et al. The PRISMA Group. Preferred reporting items for systematic reviews and meta-Analyses: the PRISMA Statement. BMJ 2009;339:b2535.
14. Welch V, Petticrew M, Tugwell P, et al. PRISMA-equity 2012 extension: reporting guidelines for systematic reviews with a focus on health equity. PLoS Med 2012;9:e1001333.
15. Cochrane Effective Practice and Organisation of Care (EPOC). What study designs should be included in an EPOC review? EPOC Resources for review authors. Oslo: Norwegian Knowledge Centre for the Health Services, 2013. http://epoc.cochrane.org/epoc-specific-resources-review-authors (accessed 30 Jun/2015).
16. Egan M, Bambra C, Petticrew M, et al. Reviewing evidence on complex social interventions: appraising implementation in systematic reviews of the health effects of organisational-level workplace interventions. J Epidemiol Community Health 2009;63:4-11.
17. Bambra CL, Hillier-Brown FC, Cairns JM, et al. How effective are interventions at reducing socioeconomic inequalities in obesity among children and adults? Two systematic reviews. Public Health Res 2015;3:1-446.
18. Michie S, Van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci 2011;6:42.
19. Policy Process and Practice. Public Health: ethical issues. London: Nuffield Council on Bioethics, 2007.
20. Effective Public Health Practice Project. Effective public health practice project quality assessment tool for quantitative studies. http://www.ephpp. ca/tools.html (accessed 30 Jun. 2015).
21. Cochrane Public Health Group. Guidance for authors. http://ph. cochrane.org/review-authors (accessed 30 Jun. 2015).
22. Ali M, Schifano F, Robinson P, et al. Impact of community pharmacy diabetes monitoring and education programme on diabetes management: a randomized controlled study. Diabet Med 2012;29:e326-33.
23. Fornos JA, Andres NF, Andres JC, et al. A pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain. Pharm World Sci 2006;28:65-72.
24. Paulos CP, Akesson Nygren CE, Celedon C, et al. Impact of a pharmaceutical care program in a community pharmacy on patients with dyslipidemia. Ann Pharmacother 2005;39:939-43.
25. Correr CJ, Melchiors AC, Fernandez-Llimos F, et al. Effects of a pharmacotherapy follow-up in community pharmacies on type 2 diabetes patients in Brazil. Int J Clin Pharm 2011;33:273-80.
26. Zaragoza-Fernandez MP, Gastelurrutia MA, Cardero M, et al. Intensive two-month intervention on diet and lifestyle in uncontrolled hypertensive patients in a community pharmacy. Latin Am J Pharm 2012;31:727-33.
27. Dhital R, Norman I, Whittlesea C, et al. The effectiveness of brief alcohol interventions delivered by community pharmacists: randomized controlled trial. Addiction 2015;110:1586-94.
28. Watson MC, Stewart D. Screening and brief interventions for alcohol misuse delivered in the community pharmacy setting: a pilot study. Report for the Chief Scientist Office, 2011.
29. Bauld L, Boyd KA, Briggs AH, et al. One-year outcomes and a cost-effectiveness analysis for smokers accessing group-based and pharmacy-led cessation services. Nicotine Tob Res 2011;13:135-45.
30. Bock BC, Hudmon KS, Christian J, et al. A tailored intervention to support pharmacy-based counseling for smoking cessation. Nicotine Tob Res 2010;12:217-25.
31. Burford O, Jiwa M, Carter O, et al. Internet-based photoaging within Australian pharmacies to promote smoking cessation: randomized controlled trial. J Med Internet Res 2013;15:e64.
32. Costello MJ, Sproule B, Victor JC, et al. Effectiveness of pharmacist counseling combined with nicotine replacement therapy: a pragmatic randomized trial with 6, 987 smokers. Cancer Causes Control 2011;22:167-80.
33. Crealey GE, McElnay JC, Maguire TA, et al. Costs and effects associated with a community pharmacy-based smoking-cessation programme. Pharmacoeconomics 1998;14:323-33.
34. Hoving C, Mudde AN, Dijk F, et al. Effectiveness of a smoking cessation intervention in Dutch pharmacies and general practices. Health Educ 2010;110:17-29.
35. Howard-Pitney B, Killen JD, Fortmann SP. Quitting chew: results from a randomized trial using nicotine patches. Exp Clin Psychopharmacol 1999;7:362-71.
36. Maguire TA, McElnay JC, Drummond A. A randomized controlled trial of a smoking cessation intervention based in community pharmacies. Addiction 2001;96:325-31.
37. Mochizuki M, Hatsugaya M, Rokujoh E, et al. Randomized controlled study on the effectiveness of community pharmacists' advice for smoking cessation by Nicorette-evaluation at three months after initiation. Yakugaku Zasshi 2004;124:989-95.
38. Sinclair HK, Bond CM, Lennox AS, et al. Training pharmacists and pharmacy assistants in the stage-of-change model of smoking cessation: a randomised controlled trial in Scotland. Tob Control 1998;7:253-61.
39. Vial RJ, Jones TE, Ruffin RE, et al. Smoking cessation program using nicotine patches linking hospital to the community. J Pharm Pract Res 2002;32:57-62.
40. Sonderskov J, Olsen J, Sabroe S, et al. Nicotine patches in smoking cessation: a randomized trial among over-the-counter customers in Denmark. Am J Epidemiol 1997;145:309-18.
41. Ahrens RA, Hower M, Best AM. Effects of weight reduction interventions by community pharmacists. J Am Pharm Assoc 2003;43:583-9.
42. Bush J, Langley CA, Patel A, et al. Evaluation of the Heart of Birmingham teaching Primary Care Trust (HoBtPCT) My Choice Weight Management Programme. Final Report; 2011.
43. Jolly K, Lewis A, Beach J, et al. Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight loss in obesity: lighten Up randomised controlled trial. BMJ 2011;343:d6500.
44. Malone M, Alger-Mayer SA. Pharmacist intervention enhances adherence to orlistat therapy. Ann Pharmacother 2003;37:1598-602.
45. Phimarn W, Pianchana P, Limpikanchakovit P, et al. Thai community pharmacist involvement in weight management in primary care to improve patient's outcomes. Int J Clin Pharm 2013;35:1208-17.
46. Steed L, Kassavou A, Madurasinghe VW, et al. Community pharmacy interventions for health promotion: effects on professional practice and health outcomes. Cochrane Database Syst Rev 2014;(7): CD011207.